"The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfiel"...
OMONTYS overdosage can elevate hemoglobin levels above the desired level, which should be managed with discontinuation or reduction of OMONTYS dosage and/or with phlebotomy, as clinically indicated [see Pharmacodynamics]. Cases of severe hypertension have been observed following overdose with ESAs [see WARNINGS AND PRECAUTIONS].
OMONTYS is contraindicated in patients with:
- Uncontrolled hypertension [see WARNINGS AND PRECAUTIONS].
- Serious allergic reactions to OMONTYS which may include anaphylaxis [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 12/19/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Omontys Information
Report Problems to the Food and Drug Administration
Find out what women really need.